Statements (52)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
microfluidic cell culture device |
| gptkbp:advantage |
real-time monitoring
dynamic microenvironment human-relevant data reduced animal use |
| gptkbp:alternativeTo |
animal testing
|
| gptkbp:component |
biomaterials
sensors membranes living cells microchannels |
| gptkbp:developedBy |
gptkb:Donald_Ingber
gptkb:Wyss_Institute_for_Biologically_Inspired_Engineering |
| gptkbp:enables |
precision medicine
personalized medicine disease modeling high-throughput screening mechanistic studies |
| gptkbp:field |
gptkb:biotechnology
gptkb:pharmacy biomedical engineering tissue engineering toxicology drug discovery regenerative medicine microfluidics |
| gptkbp:firstDescribed |
2010
|
| gptkbp:fundedBy |
gptkb:DARPA
gptkb:FDA gptkb:NIH |
| gptkbp:hasPatent |
US20120214200A1
|
| https://www.w3.org/2000/01/rdf-schema#label |
organ-on-a-chip
|
| gptkbp:limitation |
standardization
scalability complexity |
| gptkbp:relatedTo |
gptkb:lab-on-a-chip
microphysiological system organoid |
| gptkbp:SIM |
gptkb:cancer
gptkb:skin gptkb:kidney brain heart liver gut |
| gptkbp:usedFor |
toxicology studies
disease modeling drug testing simulating organ functions |
| gptkbp:bfsParent |
gptkb:Wyss_Institute_for_Biologically_Inspired_Engineering
|
| gptkbp:bfsLayer |
5
|